Related Experiment Videos
The correlation between cell surface markers and clinical features in choroidal malignant melanomas
1Institute for Cancer Studies, University Medical School, Sheffield, UK. j.lawry@sheffield.ac.uk
Eye (London, England)
|January 7, 2000
Summary
Flow cytometry identified Intercellular Adhesion Molecule-1 (ICAM-1) as a key marker for predicting uveal melanoma progression, particularly in larger tumors. This method offers a rapid phenotypic profile for therapeutic target identification.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Uveal melanoma (UM) presents challenges in predicting disease progression.
- Identifying biological markers is crucial for understanding UM behavior and developing targeted therapies.
Purpose of the Study:
- To identify markers indicative of biological characteristics in uveal melanoma cells.
- To assess adhesion (ICAM-1), immune reactivity (MHC Class I and II), cell cycle control (c-erbB-2, c-myc), and apoptosis control (bcl-2, p53) using flow cytometry.
Main Methods:
- Dual parameter (DNA/MoAb) flow cytometry was used on 63 fresh choroidal melanoma tissue samples.
- Analysis included DNA content, cell cycle, and expression of various antibodies.
- Clinical parameters were compared with marker expression using non-parametric tests.
Main Results:
- Intercellular Adhesion Molecule-1 (ICAM-1) expression was significantly higher in larger tumors (> 2000 mm³).
- c-myc, c-erbB-2, and MHC Class II expression correlated with tumor cell type, being higher in spindle cell tumors.
- No correlation was found between metastatic disease and the assessed surface markers.
Conclusions:
- Flow cytometry provides a rapid phenotypic profile for uveal melanoma.
- Cell cycle control and adhesion molecule expression are key areas for further research.
- c-erbB-2 and bcl-2 positivity in over 60% of cells suggest potential therapeutic targets.